Analyses supporting the use of digitalis glycosides in patients with heart failure were presented in a Late-Breaking Science ...
A low dose of digoxin ensures that people with heart failure are hospitalized and die less frequently. This emerges from three studies led by UMCG cardiologists Dirk Jan van Veldhuisen, Kevin Damman, ...
Oct. 30, 2002 — Digoxin may pose a risk of death for women with heart failure, according to a retrospective analysis published in the Oct. 31 issue of the New England Journal of Medicine. Yet ...
A randomized trial shows no significant difference in the primary endpoint of quality of life at 6 months between treatment with digoxin vs the beta-blocker bisoprolol (Zebeta) in patients with atrial ...
Digoxin was shown to be dangerous at high levels for atrial fibrillation (Afib) patients in a randomized trial. Meanwhile, another study suggested the benefit of genotyping for better warfarin ...
A low dose of digoxin ensures that people with heart failure are hospitalized and die less frequently. In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results